Beneficial effects of a switch to a lopinavir/ritonavir-containing regimen for patients with partial or no immune reconstitution with highly active antiretroviral therapy despite complete viral suppression.
Phase of Trial: Phase IV
Latest Information Update: 22 Jun 2011
At a glance
- Drugs Antiretrovirals; Lopinavir/ritonavir; Nucleoside reverse transcriptase inhibitors
- Indications HIV-1 infections
- Focus Therapeutic Use
- 22 Jun 2011 New trial record